Ligand Pharmaceuticals Inc. (LGND)
NASDAQ: Health Care
$12.87
0.15 | 1.18%
0.15 | 1.18%
Today's Range:
12.57 -
13.16
LGND Avg. Daily Volume:
109,700
05/25/12 - 4:00 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 12.87 |
| 52 Week High | 18.74 |
| 52 Week Low | 9.76 |
| Avg. Daily Vol. (Mil) | 0.11 |
| Beta (3 year) | 1.24 |
| Share Related Items | |
| Mkt Cap (Mil) | 253.98 |
| Shares Out (Mil) | 19.73 |
| Float (Mil) | 13.92 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.70 |
| Current Ratio | 0.90 |
| LT Debt/ Equity | 2.51 |
| Total Debt / Equity | 3.14 |
| Valuation Ratios | |
| Price Earnings | 128.70 |
| Price/Sales | 7.99 |
| Price/Book | 13.20 |
| Price/Cash Flow | 51.10 |
| Per Share Data | |
| Earnings | 0.10 |
| Sales | 1.61 |
| Book Value | 0.98 |
| Cash Flow | 0.25 |
| Business Summary | |
|---|---|
| Ligand Pharmaceuticals, Inc. focuses on drug discovery & early-stage development of pharmaceuticals that address critical unmet medical needs or that are more effective or safer than existing therapies, more convenient to administer & are cost effective. | |
| General Information | |
| 11085 North Torrey Pines Roa
La Jolla, CA 92037 |
|
| www.ligand.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 21 | |
| CEO: Mr. John L. Higgins | |
| Short Interest | |
| Current Month (Mil) | 1.23 |
| Previous Month (Mil) | 1.23 |
| Short Interest Ratio (Days) | 13.70 |
| Management Effectiveness | |
| Return on Equity | 10.70 |
| Return on Assets | 1.80 |
| Return on Investments | 3.10 |
| Profitability | |
| Gross Margin | 94.90 |
| EBIT Margin | 11.60 |
| Profit Margin | 6.50 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet